Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.
This report aims to provide a comprehensive presentation of the global market for Cannabis-based Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis-based Medicines. This report contains market size and forecasts of Cannabis-based Medicines in global, including the following market information:
Global Cannabis-based Medicines Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Cannabis-based Medicines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CBD (Cannabidiol) Based Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cannabis-based Medicines include GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, Axim Biotechnologies, Revive Therapeutics, MGC Pharmaceuticals and ECHO Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cannabis-based Medicines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cannabis-based Medicines Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Cannabis-based Medicines Market Segment Percentages, by Type, 2022 (%)
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others
Global Cannabis-based Medicines Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Cannabis-based Medicines Market Segment Percentages, by Application, 2022 (%)
Oral Solution
Tablets
Patches
Others
Global Cannabis-based Medicines Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Cannabis-based Medicines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cannabis-based Medicines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cannabis-based Medicines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cannabis-based Medicines, market overview.
Chapter 2: Global Cannabis-based Medicines market size in revenue.
Chapter 3: Detailed analysis of Cannabis-based Medicines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cannabis-based Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cannabis-based Medicines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cannabis-based Medicines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cannabis-based Medicines Overall Market Size
2.1 Global Cannabis-based Medicines Market Size: 2022 VS 2032
2.2 Global Cannabis-based Medicines Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cannabis-based Medicines Players in Global Market
3.2 Top Global Cannabis-based Medicines Companies Ranked by Revenue
3.3 Global Cannabis-based Medicines Revenue by Companies
3.4 Top 3 and Top 5 Cannabis-based Medicines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cannabis-based Medicines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cannabis-based Medicines Players in Global Market
3.6.1 List of Global Tier 1 Cannabis-based Medicines Companies
3.6.2 List of Global Tier 2 and Tier 3 Cannabis-based Medicines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cannabis-based Medicines Market Size Markets, 2022 & 2032
4.1.2 CBD (Cannabidiol) Based
4.1.3 THC (Tetrahydrocannabinol) Based
4.1.4 Others
4.2 By Type - Global Cannabis-based Medicines Revenue & Forecasts
4.2.1 By Type - Global Cannabis-based Medicines Revenue, 2018-2023
4.2.2 By Type - Global Cannabis-based Medicines Revenue, 2024-2032
4.2.3 By Type - Global Cannabis-based Medicines Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cannabis-based Medicines Market Size, 2022 & 2032
5.1.2 Oral Solution
5.1.3 Tablets
5.1.4 Patches
5.1.5 Others
5.2 By Application - Global Cannabis-based Medicines Revenue & Forecasts
5.2.1 By Application - Global Cannabis-based Medicines Revenue, 2018-2023
5.2.2 By Application - Global Cannabis-based Medicines Revenue, 2024-2032
5.2.3 By Application - Global Cannabis-based Medicines Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Cannabis-based Medicines Market Size, 2022 & 2032
6.2 By Region - Global Cannabis-based Medicines Revenue & Forecasts
6.2.1 By Region - Global Cannabis-based Medicines Revenue, 2018-2023
6.2.2 By Region - Global Cannabis-based Medicines Revenue, 2024-2032
6.2.3 By Region - Global Cannabis-based Medicines Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Cannabis-based Medicines Revenue, 2018-2032
6.3.2 US Cannabis-based Medicines Market Size, 2018-2032
6.3.3 Canada Cannabis-based Medicines Market Size, 2018-2032
6.3.4 Mexico Cannabis-based Medicines Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Cannabis-based Medicines Revenue, 2018-2032
6.4.2 Germany Cannabis-based Medicines Market Size, 2018-2032
6.4.3 France Cannabis-based Medicines Market Size, 2018-2032
6.4.4 U.K. Cannabis-based Medicines Market Size, 2018-2032
6.4.5 Italy Cannabis-based Medicines Market Size, 2018-2032
6.4.6 Russia Cannabis-based Medicines Market Size, 2018-2032
6.4.7 Nordic Countries Cannabis-based Medicines Market Size, 2018-2032
6.4.8 Benelux Cannabis-based Medicines Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Cannabis-based Medicines Revenue, 2018-2032
6.5.2 China Cannabis-based Medicines Market Size, 2018-2032
6.5.3 Japan Cannabis-based Medicines Market Size, 2018-2032
6.5.4 South Korea Cannabis-based Medicines Market Size, 2018-2032
6.5.5 Southeast Asia Cannabis-based Medicines Market Size, 2018-2032
6.5.6 India Cannabis-based Medicines Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Cannabis-based Medicines Revenue, 2018-2032
6.6.2 Brazil Cannabis-based Medicines Market Size, 2018-2032
6.6.3 Argentina Cannabis-based Medicines Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cannabis-based Medicines Revenue, 2018-2032
6.7.2 Turkey Cannabis-based Medicines Market Size, 2018-2032
6.7.3 Israel Cannabis-based Medicines Market Size, 2018-2032
6.7.4 Saudi Arabia Cannabis-based Medicines Market Size, 2018-2032
6.7.5 UAE Cannabis-based Medicines Market Size, 2018-2032
7 Cannabis-based Medicines Companies Profiles
7.1 GW Pharmaceuticals plc
7.1.1 GW Pharmaceuticals plc Company Summary
7.1.2 GW Pharmaceuticals plc Business Overview
7.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Major Product Offerings
7.1.4 GW Pharmaceuticals plc Cannabis-based Medicines Revenue in Global Market (2018-2023)
7.1.5 GW Pharmaceuticals plc Key News & Latest Developments
7.2 INSYS Therapeutics
7.2.1 INSYS Therapeutics Company Summary
7.2.2 INSYS Therapeutics Business Overview
7.2.3 INSYS Therapeutics Cannabis-based Medicines Major Product Offerings
7.2.4 INSYS Therapeutics Cannabis-based Medicines Revenue in Global Market (2018-2023)
7.2.5 INSYS Therapeutics Key News & Latest Developments
7.3 Aequus Pharmaceuticals
7.3.1 Aequus Pharmaceuticals Company Summary
7.3.2 Aequus Pharmaceuticals Business Overview
7.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Major Product Offerings
7.3.4 Aequus Pharmaceuticals Cannabis-based Medicines Revenue in Global Market (2018-2023)
7.3.5 Aequus Pharmaceuticals Key News & Latest Developments
7.4 Axim Biotechnologies
7.4.1 Axim Biotechnologies Company Summary
7.4.2 Axim Biotechnologies Business Overview
7.4.3 Axim Biotechnologies Cannabis-based Medicines Major Product Offerings
7.4.4 Axim Biotechnologies Cannabis-based Medicines Revenue in Global Market (2018-2023)
7.4.5 Axim Biotechnologies Key News & Latest Developments
7.5 Revive Therapeutics
7.5.1 Revive Therapeutics Company Summary
7.5.2 Revive Therapeutics Business Overview
7.5.3 Revive Therapeutics Cannabis-based Medicines Major Product Offerings
7.5.4 Revive Therapeutics Cannabis-based Medicines Revenue in Global Market (2018-2023)
7.5.5 Revive Therapeutics Key News & Latest Developments
7.6 MGC Pharmaceuticals
7.6.1 MGC Pharmaceuticals Company Summary
7.6.2 MGC Pharmaceuticals Business Overview
7.6.3 MGC Pharmaceuticals Cannabis-based Medicines Major Product Offerings
7.6.4 MGC Pharmaceuticals Cannabis-based Medicines Revenue in Global Market (2018-2023)
7.6.5 MGC Pharmaceuticals Key News & Latest Developments
7.7 ECHO Pharmaceuticals
7.7.1 ECHO Pharmaceuticals Company Summary
7.7.2 ECHO Pharmaceuticals Business Overview
7.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Major Product Offerings
7.7.4 ECHO Pharmaceuticals Cannabis-based Medicines Revenue in Global Market (2018-2023)
7.7.5 ECHO Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cannabis-based Medicines Market Opportunities & Trends in Global Market
Table 2. Cannabis-based Medicines Market Drivers in Global Market
Table 3. Cannabis-based Medicines Market Restraints in Global Market
Table 4. Key Players of Cannabis-based Medicines in Global Market
Table 5. Top Cannabis-based Medicines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cannabis-based Medicines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cannabis-based Medicines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cannabis-based Medicines Product Type
Table 9. List of Global Tier 1 Cannabis-based Medicines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cannabis-based Medicines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cannabis-based Medicines Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Cannabis-based Medicines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cannabis-based Medicines Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Cannabis-based Medicines Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Cannabis-based Medicines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cannabis-based Medicines Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Cannabis-based Medicines Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Cannabis-based Medicines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cannabis-based Medicines Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Cannabis-based Medicines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cannabis-based Medicines Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Cannabis-based Medicines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cannabis-based Medicines Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Cannabis-based Medicines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cannabis-based Medicines Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Cannabis-based Medicines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cannabis-based Medicines Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Cannabis-based Medicines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cannabis-based Medicines Revenue, (US$, Mn), 2024-2032
Table 30. GW Pharmaceuticals plc Company Summary
Table 31. GW Pharmaceuticals plc Cannabis-based Medicines Product Offerings
Table 32. GW Pharmaceuticals plc Cannabis-based Medicines Revenue (US$, Mn) & (2018-2023)
Table 33. GW Pharmaceuticals plc Key News & Latest Developments
Table 34. INSYS Therapeutics Company Summary
Table 35. INSYS Therapeutics Cannabis-based Medicines Product Offerings
Table 36. INSYS Therapeutics Cannabis-based Medicines Revenue (US$, Mn) & (2018-2023)
Table 37. INSYS Therapeutics Key News & Latest Developments
Table 38. Aequus Pharmaceuticals Company Summary
Table 39. Aequus Pharmaceuticals Cannabis-based Medicines Product Offerings
Table 40. Aequus Pharmaceuticals Cannabis-based Medicines Revenue (US$, Mn) & (2018-2023)
Table 41. Aequus Pharmaceuticals Key News & Latest Developments
Table 42. Axim Biotechnologies Company Summary
Table 43. Axim Biotechnologies Cannabis-based Medicines Product Offerings
Table 44. Axim Biotechnologies Cannabis-based Medicines Revenue (US$, Mn) & (2018-2023)
Table 45. Axim Biotechnologies Key News & Latest Developments
Table 46. Revive Therapeutics Company Summary
Table 47. Revive Therapeutics Cannabis-based Medicines Product Offerings
Table 48. Revive Therapeutics Cannabis-based Medicines Revenue (US$, Mn) & (2018-2023)
Table 49. Revive Therapeutics Key News & Latest Developments
Table 50. MGC Pharmaceuticals Company Summary
Table 51. MGC Pharmaceuticals Cannabis-based Medicines Product Offerings
Table 52. MGC Pharmaceuticals Cannabis-based Medicines Revenue (US$, Mn) & (2018-2023)
Table 53. MGC Pharmaceuticals Key News & Latest Developments
Table 54. ECHO Pharmaceuticals Company Summary
Table 55. ECHO Pharmaceuticals Cannabis-based Medicines Product Offerings
Table 56. ECHO Pharmaceuticals Cannabis-based Medicines Revenue (US$, Mn) & (2018-2023)
Table 57. ECHO Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Cannabis-based Medicines Segment by Type in 2022
Figure 2. Cannabis-based Medicines Segment by Application in 2022
Figure 3. Global Cannabis-based Medicines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cannabis-based Medicines Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Cannabis-based Medicines Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cannabis-based Medicines Revenue in 2022
Figure 8. By Type - Global Cannabis-based Medicines Revenue Market Share, 2018-2032
Figure 9. By Application - Global Cannabis-based Medicines Revenue Market Share, 2018-2032
Figure 10. By Type - Global Cannabis-based Medicines Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Cannabis-based Medicines Revenue Market Share, 2018-2032
Figure 12. By Application - Global Cannabis-based Medicines Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Cannabis-based Medicines Revenue Market Share, 2018-2032
Figure 14. By Region - Global Cannabis-based Medicines Revenue Market Share, 2018-2032
Figure 15. By Country - North America Cannabis-based Medicines Revenue Market Share, 2018-2032
Figure 16. US Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Cannabis-based Medicines Revenue Market Share, 2018-2032
Figure 20. Germany Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 21. France Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Cannabis-based Medicines Revenue Market Share, 2018-2032
Figure 28. China Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 32. India Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Cannabis-based Medicines Revenue Market Share, 2018-2032
Figure 34. Brazil Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Cannabis-based Medicines Revenue Market Share, 2018-2032
Figure 37. Turkey Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Cannabis-based Medicines Revenue, (US$, Mn), 2018-2032
Figure 41. GW Pharmaceuticals plc Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. INSYS Therapeutics Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Aequus Pharmaceuticals Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Axim Biotechnologies Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Revive Therapeutics Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. MGC Pharmaceuticals Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. ECHO Pharmaceuticals Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
